- Home
- FG vs ALKS Comparison
FG vs ALKS Comparison
Compare FG & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FG
- ALKS
- Stock Information
- Founded
- FG 1959
- ALKS 1987
- Country
- FG United States
- ALKS Ireland
- Employees
- FG N/A
- ALKS N/A
- Industry
- FG Life Insurance
- ALKS Biotechnology: Pharmaceutical Preparations
- Sector
- FG Finance
- ALKS Health Care
- Exchange
- FG Nasdaq
- ALKS Nasdaq
- Market Cap
- FG 4.3B
- ALKS 4.9B
- IPO Year
- FG N/A
- ALKS 1991
- Fundamental
- Price
- FG $34.44
- ALKS $26.52
- Analyst Decision
- FG Hold
- ALKS Strong Buy
- Analyst Count
- FG 3
- ALKS 14
- Target Price
- FG $44.33
- ALKS $41.29
- AVG Volume (30 Days)
- FG 139.4K
- ALKS 1.9M
- Earning Date
- FG 11-05-2025
- ALKS 10-23-2025
- Dividend Yield
- FG 2.56%
- ALKS N/A
- EPS Growth
- FG N/A
- ALKS 21.99
- EPS
- FG 2.52
- ALKS 2.08
- Revenue
- FG $5,309,000,000.00
- ALKS $1,505,296,000.00
- Revenue This Year
- FG N/A
- ALKS N/A
- Revenue Next Year
- FG $19.65
- ALKS $1.66
- P/E Ratio
- FG $13.66
- ALKS $12.77
- Revenue Growth
- FG 1.86
- ALKS N/A
- 52 Week Low
- FG $30.01
- ALKS $25.17
- 52 Week High
- FG $50.75
- ALKS $36.45
- Technical
- Relative Strength Index (RSI)
- FG 52.24
- ALKS 39.42
- Support Level
- FG $34.01
- ALKS $26.70
- Resistance Level
- FG $34.95
- ALKS $28.65
- Average True Range (ATR)
- FG 0.66
- ALKS 1.09
- MACD
- FG -0.13
- ALKS -0.32
- Stochastic Oscillator
- FG 33.71
- ALKS 20.71
About FG F&G Annuities & Life Inc.
F&G Annuities & Life Inc is a provider of insurance solutions serving retail annuity and life customers as well as institutional clients. Through its insurance subsidiaries, including FGL Insurance and Fidelity & Guaranty Life Insurance Company of New York it markets a broad portfolio of deferred annuities (fixed indexed annuities (FIAs) and multi-year guarantee annuities (MYGAs) or other fixed rate annuities), immediate annuities, indexed universal life (IUL) insurance, funding agreements through funding agreement-backed notes (FABN) issuances and the Federal Home Loan Bank of Atlanta (FHLB)), and pension risk transfer (PRT) solutions.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.